hallucinogen dependence Gene Set

Dataset DISEASES Text-mining Gene-Disease Association Evidence Scores
Category disease or phenotype associations
Type disease
Description A drug dependence that involves the continued use of hallucinogenic drugs despite problems related to use of the substance. (Human Disease Ontology, DOID_9977)
Similar Terms
Downloads & Tools

Genes

21 genes co-occuring with the disease hallucinogen dependence in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.

Symbol Name Standardized Value
CNR1 cannabinoid receptor 1 (brain) 1.98947
ANKFN1 ankyrin-repeat and fibronectin type III domain containing 1 1.83909
FAAH fatty acid amide hydrolase 1.63411
HCRTR2 hypocretin (orexin) receptor 2 1.46407
GABRA2 gamma-aminobutyric acid (GABA) A receptor, alpha 2 1.43771
CHRM5 cholinergic receptor, muscarinic 5 1.40132
HCRTR1 hypocretin (orexin) receptor 1 1.11393
ADGRL4 adhesion G protein-coupled receptor L4 1.07824
PATE1 prostate and testis expressed 1 0.94577
HCRT hypocretin (orexin) neuropeptide precursor 0.906498
NRG1 neuregulin 1 0.88434
AIM2 absent in melanoma 2 0.879833
CHRNA5 cholinergic receptor, nicotinic, alpha 5 (neuronal) 0.772479
MEGF6 multiple EGF-like-domains 6 0.756971
FOSB FBJ murine osteosarcoma viral oncogene homolog B 0.679499
PENK proenkephalin 0.660404
COMT catechol-O-methyltransferase 0.629635
C6ORF25 chromosome 6 open reading frame 25 0.431519
FGD1 FYVE, RhoGEF and PH domain containing 1 0.431519
DRD2 dopamine receptor D2 0.326281
ABCB1 ATP-binding cassette, sub-family B (MDR/TAP), member 1 0.168854